HOTH News and Press, Hoth Therapeutics Inc. From 07/22/19

Ultra-thinly traded nano cap Hoth Therapeutics ( HOTH ) is up  9% , albeit on only 369 shares, on the heels of positive results from a pilot study of BioLexa for patients with diabetic skin ulcers. More news on: Hoth Therapeutics, Inc., Healthcare stocks news, Stocks on the move, ...

July 22, 2019 Palm Beach, FL – July 22, 2019 –  According to a report from Grand View Research, the global diabetic foot ulcer treatment market size is expected to reach a value of USD 6.82 billion by 2025, according to a new report by Grand View Research, I...

NEW YORK , July 22, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well...

Hoth Therapeutics (NASDAQ: HOTH ) has entered into an exclusive license option agreement with the George Washington University (GW) pertaining to its intellectual property on the use of Aprepitant in treating skin-related and other side effects from drugs used to treat cancer. More news ...

NEW YORK , July 15, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and...

June 27, 2019 Palm Beach, FL – June 27, 2019 –  In today’s medical and financial environments, defending against risks is essential. In the financial world, financial planning can protect against most risks… in the medical world however, it is the ...

NEW YORK , June 27, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chro...

Gainers:  Roan Resources (NYSE: ROAN ) +44% . Arbutus Biopharma Corporation (NASDAQ: ABUS ) +42% . China Internet Nationwide Financial Services (NASDAQ: CIFS ) +28% . DiaMedica Therapeutics (NASDAQ: DMAC ) +27% . B Communications (NASDAQ: BCOM ) +24% . Hebron Technology (NASDAQ: ...

NEW YORK , June 13, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chron...

June 11, 2019 Palm Beach, FL – June 11, 2019 – Recent reports by industry specialists show that the Atopic Dermatitis Drugs Market Size Worth $6.41 Billion By 2022, exhibiting a CAGR of 6.6% during the forecast period. This is an increase from the 2016 market reven...